Follow the Allergy Therapeutics Plc stock price and the full insider trade history of the company, a listed equity based in United Kingdom. Shares are quoted on the UK market, under the supervision of RNS (LSE). Market capitalisation: €378.7m. The latest transaction was disclosed on 15 January 2025 (Purchase). Among the most active insiders: ZQ Capital Management Limited. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Allergy Therapeutics Plc 是一家专注于开发过敏免疫疗法的公司。该公司在伦敦证券交易所上市。